Quantum Genesis AI Corp. (OTC: QGAI) announced today that the Caveat Emptor designation previously applied to the Company’s securities by OTC Markets Group has been removed. The removal marks a significant milestone for the company, which worked cooperatively with OTC Markets to provide information and respond to inquiries during the review period.
The Caveat Emptor designation is applied by OTC Markets to inform investors that there may be public interest concerns associated with a company's stock, such as a lack of current public information, a questionable promotional campaign, or other regulatory issues. Its removal indicates that Quantum Genesis AI has addressed these concerns and met the necessary standards for transparency and disclosure.
“We appreciate the time and attention that OTC Markets dedicated to this matter and are pleased that the review process has concluded with the removal of the Caveat Emptor designation,” said Naveen Kulkarni, Chief Executive Officer of Quantum Genesis AI Corp. “Throughout this process, our focus remained on transparency, responsiveness, and constructive engagement. We thank OTC Markets for their professionalism and assistance, and we remain committed to maintaining open communication with our shareholders and the marketplace.”
The company continues to advance its strategic initiatives in artificial intelligence, computational modeling, and scientific innovation, while maintaining its commitment to responsible corporate governance and public company compliance. Quantum Genesis AI intends to provide timely updates regarding its business activities and corporate developments through its public disclosures and shareholder communications.
For more information and updates, please visit www.qgaicorp.com and the Company’s profile at www.otcmarkets.com/stock/QGAI.
Quantum Genesis AI Corp. is focused on advancing next-generation technologies at the intersection of artificial intelligence, computational modeling, and scientific innovation. The Company’s strategy includes leveraging advanced data-driven tools to support research, discovery, and technology development across emerging sectors while maintaining a commitment to transparency and responsible corporate governance.
